Advanced search
Companies (1983)
Target Corporation specializes in retail distribution. Net sales break down by family of products as follows: - household and beauty products (26.5%) ; - furnishings and decorative items (19.7%) ; - food and beverage (19.6%); - electronic products, sp ...
Capitalization | 66 990 M USD |
---|---|
Change | +0.59% |
1-year price change | +2.27% |
KKR & Co. Inc. is an investment company, which offers alternative asset management as well as capital markets and insurance solutions. The Company's asset management business offers a range of investment management services to fund investors around the wo ...
Capitalization | 94 118 M USD |
---|---|
Change | +0.02% |
1-year price change | +28.04% |
The Intesa Sanpaolo Group is one of the first European groups to have made a strong commitment to ESG. It is also the first in the world, in terms of social impact, to focus on the climate. The group is the leader in Italy (13.6 million clients; >3,300 br ...
Capitalization | 69 885 M USD |
---|---|
Change | -0.84% |
1-year price change | +34.27% |
Safran is a high technology international group, a leading equipment provider in the Aerospace and Defense markets. The group specializes in the design, manufacturing, and marketing of equipment and systems of high technology mechanical and electronic equ ...
Capitalization | 91 512 M USD |
---|---|
Change | -1.07% |
1-year price change | +26.99% |
The Trade Desk, Inc. specializes in the development and operation of an online platform dedicated to the purchase of advertising space. Based on data, the platform allows advertisers to optimize the placement, execution and management of advertising campa ...
Capitalization | 48 653 M USD |
---|---|
Change | +0.43% |
1-year price change | +38.83% |
Alnylam Pharmaceuticals, Inc. is a clinical-stage company. The Company is engaged in developing mRNA cell therapies for the treatment of autoimmune diseases. The Companyâs lead product candidate, Descartes-08, is an autologous mRNA CAR-T directed agains ...
Capitalization | 31 456 M USD |
---|---|
Change | +0.94% |
1-year price change | +31.15% |
CHINA MERCHANTS SECURITIES CO., LTD is a China-based company, principally engaged in security businesses. The Company operates its businesses through brokerage and wealth management business, including stocks, funds, bonds and financial products trading; ...
Capitalization | 15 055 M USD |
---|---|
Change | -0.65% |
1-year price change | +0.29% |
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell ...
Capitalization | 19 272 M USD |
---|---|
Change | +0.29% |
1-year price change | -24.11% |
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modali ...
Capitalization | 14 473 M USD |
---|---|
Change | -0.90% |
1-year price change | +57.35% |
CNA Financial Corporation is an insurance holding company. The Companyâs segments include Specialty, Commercial and International, and Life & Group and Corporate & Other. The Specialty segment offers management and professional liability and other cover ...
Capitalization | 12 265 M USD |
---|---|
Change | -1.02% |
1-year price change | +5.77% |
Antero Resources Corporation is an independent natural gas and natural gas liquids (NGLs) company. The Company is engaged in the acquisition, development and production of unconventional properties located in the Appalachian Basin in West Virginia and Ohi ...
Capitalization | 10 350 M USD |
---|---|
Change | -2.07% |
1-year price change | +43.78% |
Zomato Limited operates as an Internet portal that helps in connecting the users, restaurant partners and delivery partners. The Company also provides platform to restaurant partners to advertise themselves to the target audience in India and abroad and s ...
Capitalization | 21 456 M USD |
---|---|
Change | +0.06% |
1-year price change | +67.80% |
Hologic, Inc. is the world leader in the design, manufacturing and marketing of diagnostic products, medical imaging systems and surgical products dedicated to women's health. Net sales break down by area of application as follows: - molecular diagnostic ...
Capitalization | 17 149 M USD |
---|---|
Change | +0.87% |
1-year price change | +3.74% |
ImmunoGen, Inc. is a commercial-stage biotechnology company. The Company is focused on developing and commercializing of antibody- drug conjugates (ADCs) to improve outcomes for cancer patients. An ADC with the Company's technology comprises an antibody t ...
Capitalization | 8 359 M USD |
---|---|
Change | -.--% |
1-year price change | +5.33% |
Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on neuroscience that combines an understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous ...
Capitalization | 7 342 M USD |
---|---|
Change | +1.64% |
1-year price change | -3.40% |
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), refe ...
Capitalization | 8 369 M USD |
---|---|
Change | +0.85% |
1-year price change | -23.05% |
Revolution Medicines, Inc. is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The Companyâs research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refer ...
Capitalization | 6 091 M USD |
---|---|
Change | +1.65% |
1-year price change | +30.86% |
Loongson Technology Corp Ltd is a China-based company mainly engaged in the research, development, manufacturing, and servicing of computer processing units (CPU) and related chips. The Company's main products include Loongson series CPU and related chips ...
Capitalization | 4 726 M USD |
---|---|
Change | +1.77% |
1-year price change | -21.09% |
Roivant Sciences Ltd. is a commercial-stage biopharmaceutical company that seeks to improve the lives of patients by accelerating the development and commercialization of medicines that matter. The Companyâs pipeline is focused on inflammation and immun ...
Capitalization | 7 742 M USD |
---|---|
Change | +1.62% |
1-year price change | -5.16% |
Xpeng Inc is a China-based company engaged in design, development, production and sales of smart electric vehicles (Smart EV). The Company's primary products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P ...
Capitalization | 7 860 M USD |
---|---|
Change | -4.81% |
1-year price change | -45.72% |
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development a ...
Capitalization | 6 651 M USD |
---|---|
Change | +1.07% |
1-year price change | -8.90% |
Olin Corporation is a vertically integrated global manufacturer and distributor of chemical products and a manufacturer of ammunition. The Company operates through three segments: Chlor Alkali Products and Vinyls, Epoxy and Winchester. The Chlor Alkali Pr ...
Capitalization | 5 526 M USD |
---|---|
Change | -1.19% |
1-year price change | -15.25% |
Ubiquiti Inc. is engaged in developing technology platforms for distributed Internet access, unified information technology, and consumer electronics for professional, home and personal use. Its solutions are categorized into three categories: networking ...
Capitalization | 8 960 M USD |
---|---|
Change | -0.72% |
1-year price change | +5.42% |
PI Industries Limited is a holding company. The Company is engaged in the manufacturing and distribution of agro chemicals. The Company operates through two segments: Agro chemicals, and Pharma. The Agro chemicals segment includes Agchem exports (CSM) and ...
Capitalization | 6 880 M USD |
---|---|
Change | +0.06% |
1-year price change | +7.90% |
Blue Owl Capital Corporation is a specialty finance company focused on lending to United States middle-market companies. The Companyâs investment objective is to generate current income and, to a lesser extent, capital appreciation by targeting investme ...
Capitalization | 6 060 M USD |
---|---|
Change | +0.32% |
1-year price change | +5.69% |
Credit Acceptance Corporation is engaged in offering that enable automobile dealers to sell vehicles to consumers. The Companyâs financing programs are offered through a nationwide network of automobile dealers. Its loan portfolio consists of two portfo ...
Capitalization | 6 286 M USD |
---|---|
Change | +0.49% |
1-year price change | -2.10% |
CyberArk Software Ltd is an Israel-based provider of information technology (IT) security solutions that protect organizations from cyber-attacks. The Company's software solutions are focused on protecting privileged accounts, which have become a critical ...
Capitalization | 11 696 M USD |
---|---|
Change | +1.20% |
1-year price change | +25.23% |
Five Below, Inc. is a specialty value retailer offering merchandise targeted at the tween and teen demographic. Its assortment of products, including select brands and licensed merchandise. It is engaged in offering a group of products, including leisure, ...
Capitalization | 5 974 M USD |
---|---|
Change | -2.12% |
1-year price change | -50.19% |
Twilio Inc. provides a customer engagement platform comprising communications application programming interfaces. It enables developers to embed numerous forms of messaging, voice, and email interactions into their customer-facing applications, and softwa ...
Capitalization | 9 659 M USD |
---|---|
Change | +1.65% |
1-year price change | -24.40% |
Chord Energy Corporation is an independent exploration and production company, which is engaged in the acquisition, exploration, development and production of crude oil, natural gas liquids (NGL) and natural gas. The Companyâs operations are focused on ...
Capitalization | 7 239 M USD |
---|---|
Change | -2.37% |
1-year price change | +1.97% |
Telefonica Deutschland Holding AG is a Germany-based company in the telecommunications sector. The Company offers mobile and fixed-line services, providing voice, data and other services to private and business customers, as well as digital products and s ...
Capitalization | 6 888 M USD |
---|---|
Change | -1.74% |
1-year price change | 0.00% |
Vaxcyte Inc. is a clinical-stage vaccine company. It is engaged in developing a spectrum conjugate and protein vaccines to prevent or treat bacterial infectious diseases. Its lead candidate, VAX-24, is a Phase III-ready 24-valent, carrier-sparing pneumoco ...
Capitalization | 8 297 M USD |
---|---|
Change | +1.97% |
1-year price change | +23.82% |
Murphy Oil Corporation is an independent oil and gas exploration and production company. The Company is engaged in both onshore and offshore operations and properties. The Companyâs geographic segments include the United States, Canada, and all other co ...
Capitalization | 6 292 M USD |
---|---|
Change | -2.69% |
1-year price change | -5.93% |
Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Co ...
Capitalization | 7 970 M USD |
---|---|
Change | +3.20% |
1-year price change | -39.75% |
Conroy Gold and Natural Resources PLC is a resource company, which is engaged in exploring and developing gold projects in Ireland and Finland. Its projects include Clay Lake Gold Target, Clontibret Gold Target, Slieve Glah Gold Targets, Glenish Gold Targ ...
Capitalization | 3 M USD |
---|---|
Change | +6.67% |
1-year price change | -59.32% |
Iceni Gold Limited is an Australia-based gold exploration company that is exploring the 14 Mile Well Project in the Laverton Greenstone Belt of Western Australia. The project is situated midway between the gold mining townships of Leonora and Laverton and ...
Capitalization | 13 M USD |
---|---|
Change | +25.35% |
1-year price change | +71.15% |
OMAT Advanced Materials Guangdong Co Ltd is a China-based company principally engaged in the research, development, production and sales of high-performance sputtering targets. The Company's main products include copper target, aluminum target, molybdenum ...
Capitalization | 416 M USD |
---|---|
Change | +0.16% |
1-year price change | 0.00% |
Konfoong Materials International Co Ltd is a company engaged in research, development, production and sales of sputtering targets. The Company's products include aluminum targets, titanium targets, tantalum targets and tungsten-titanium targets, which are ...
Capitalization | 1 735 M USD |
---|---|
Change | -1.56% |
1-year price change | -20.11% |
Pieris Pharmaceuticals, Inc. is a biotechnology company, which discovers and develops Anticalin-based drugs to target validated disease pathways. The Companyâs clinical pipeline consists of immuno-oncology (IO), bispecific in partnership with collaborat ...
Capitalization | 11 M USD |
---|---|
Change | -3.23% |
1-year price change | -42.31% |
Acepodia Inc is engaged in the research and development of new anti-cancer drugs. The Company uses antibody-cell conjugation (ACC) and immune cells. The products include Gamma delta 2T cell platform including ACE1831 (ACE-gdT-CD20) an antibody linked to s ...
Capitalization | 437 M USD |
---|---|
Change | +0.60% |
1-year price change | -26.65% |
Halcones Precious Metals Corp. is a Canada-based exploration company focused on gold, silver and copper exploration. The Company is engaged in exploring for and developing gold-silver projects in the Maricunga Belt, Chile, the premiere gold mining distric ...
Capitalization | 3 M USD |
---|---|
Change | +20.00% |
1-year price change | -40.00% |
Delta-Fly Pharma, Inc. is a Japan-based company principally engaged in the research, development, manufacture and sale of pharmaceuticals. The Company's development pipeline includes anticancer drug candidate compound DFP-10917 whose target disease is ref ...
Capitalization | 31 M USD |
---|---|
Change | -0.82% |
1-year price change | -40.39% |
Halcones Precious Metals Corp. is a Canada-based exploration company focused on gold, silver and copper exploration. The Company is engaged in exploring for and developing gold-silver projects in the Maricunga Belt, Chile, the premiere gold mining distric ...
Capitalization | 150 253 USD |
---|---|
Change | +20.00% |
1-year price change | -76.92% |
Betawave Corporation provides online marketing solutions for Websites targeting youth and moms. The Company specializes in aggregating and distributing marketing content on a selected network of targeted sites, mostly virtual worlds and gaming, for which ...
Capitalization | 5 USD |
---|---|
Change | -.--% |
1-year price change | -.--% |
Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company is into exploring strategic alternatives to maximize stockholder value. It is engaging in ...
Capitalization | 3 M USD |
---|---|
Change | -4.41% |
1-year price change | -48.08% |
Bowen Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. The Co ...
Capitalization | 97 M USD |
---|---|
Change | 0.00% |
1-year price change | +2.52% |
Thor Medical ASA, formerly Nordic Nanovector ASA, is a Norway-based biopharmaceutical company. The Company is engaged in the development and commercialization of targeted therapeutics for hematological cancers. Its main product is Betalutin, a CD37-target ...
Capitalization | 23 M USD |
---|---|
Change | +1.76% |
1-year price change | -19.53% |
Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The Company has created a pipeline of the ...
Capitalization | 5 M USD |
---|---|
Change | +4.63% |
1-year price change | -68.78% |
Deltagen, Inc. is a provider of drug discovery tools and services to the biopharmaceutical industry. The Company offers a suite of programs designed to manage the efficiency of drug discovery, including access to biological models, as well as both small-m ...
Capitalization | 32 USD |
---|---|
Change | -99.00% |
1-year price change | 0.00% |
Ocean Biomedical, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The Company helps to accelerates the development and commerciali ...
Capitalization | 38 M USD |
---|---|
Change | -3.64% |
1-year price change | +60.61% |
ReNeuron Group plc is a United Kingdom-based clinical-stage stem cell company. The Company is engaged in the development of stem cell therapies targeting areas of unmet or poorly met medical need. It has developed a stem cell-derived, exosome-based, drug ...
Capitalization | 2 M USD |
---|---|
Change | -2.17% |
1-year price change | -3.57% |
Equillium, Inc. is a clinical-stage biotechnology company. It is engaged in developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. The Companyâs pipeline consists of immunomodulatory assets and ...
Capitalization | 23 M USD |
---|---|
Change | +2.70% |
1-year price change | -5.96% |
Bicycle Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully sy ...
Capitalization | 1 348 M USD |
---|---|
Change | +3.22% |
1-year price change | +11.78% |
HYUNGJI Innovation and Creative Company Limited, formerly WOOSUNG INNOVATION & CREATIVE Co.,Ltd is a Korea-based company engaged in the manufacture and marketing of menâs apparels. The Company has four principal brands: YEZAC, which is a luxury styling ...
Capitalization | 12 M USD |
---|---|
Change | -0.45% |
1-year price change | -27.68% |
ABL Bio Inc. is a company mainly engaged in the development of biopharmaceuticals. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific ...
Capitalization | 1 035 M USD |
---|---|
Change | -0.51% |
1-year price change | +20.12% |
Aura Renewable Acquisitions plc is a United Kingdom-based holding company. The principal activity of the Company is focused on targeting various businesses operating in the global renewable energy sector supply chain. The purpose of the Company is to seek ...
Capitalization | 737 218 USD |
---|---|
Change | 0.00% |
1-year price change | +4.76% |
Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company is developing proprietary antibody-based therapeutics to treat multiple human diseases. Its pipeline of novel product candidates is designed to target ...
Capitalization | 113 M USD |
---|---|
Change | -2.44% |
1-year price change | -48.72% |
Perseus Proteomics Inc is a Japan-based company principally engaged in the research, development, manufacture and sale of pharmaceuticals. The Company is involved in the research and development of therapeutic drugs for cancer and other diseases and relat ...
Capitalization | 41 M USD |
---|---|
Change | -2.89% |
1-year price change | -23.95% |
Sage Therapeutics, Inc. is a biopharmaceutical company. The Company has developed the two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. The Company is targeting diseas ...
Capitalization | 639 M USD |
---|---|
Change | +1.51% |
1-year price change | -50.25% |
Ikena Oncology, Inc. is a targeted oncology company. The Company is focused on developing differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. The ...
Capitalization | 79 M USD |
---|---|
Change | +1.84% |
1-year price change | -15.74% |
Apogee Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and ...
Capitalization | 2 192 M USD |
---|---|
Change | +1.39% |
1-year price change | +36.08% |
BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, ...
Capitalization | 24 M USD |
---|---|
Change | +1.17% |
1-year price change | +23.75% |
Pegasus Digital Mobility Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesse ...
Capitalization | 61 M USD |
---|---|
Change | +8.00% |
1-year price change | -56.02% |
Hawkeye Systems, Inc. seeks to acquire, merge or consolidate with another company (a target business). The Company is pursuing opportunities to invest in, acquire, merge or consolidate with a target business participating in diversified industries, such a ...
Capitalization | 4 M USD |
---|---|
Change | +99.80% |
1-year price change | +566.53% |
Crown Baus Capital Corp. is focused on becoming a global acquisitions-based company targeting high-tech industries and financial services. The Company uses several consultants to assist in locating potential target companies and procure the financial reso ...
Capitalization | 16 105 USD |
---|---|
Change | -.--% |
1-year price change | -.--% |
Cidara Therapeutics, Inc. is a biotechnology company. The Company is developing targeted immunotherapies designed for patients facing serious diseases. The Companyâs portfolio comprises various treatment and prevention paradigms, including drug-Fc conju ...
Capitalization | 55 M USD |
---|---|
Change | -0.90% |
1-year price change | -24.12% |
Reyna Gold Corp. is a Canada-based company focused on gold exploration in Northwestern Mexico. The Companyâs principal business activity is the acquisition and exploration of mineral properties. Its projects include La Gloria, El Durazno, La Centella, a ...
Capitalization | 1 M USD |
---|---|
Change | +20.00% |
1-year price change | -50.00% |
Mercato Partners Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more busi ...
Capitalization | 118 M USD |
---|---|
Change | +18.18% |
1-year price change | -90.03% |
Chemomab Therapeutics Ltd, formerly known as Anchiano Therapeutics Ltd, is a Israel-based biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of cancers. Its therapeu ...
Capitalization | 14 M USD |
---|---|
Change | +1.80% |
1-year price change | +93.12% |
ATLED CORP. is a Japan-based company mainly engaged in the development and sale of workflow products. The workflow products are the digitization of the business flow from deliberation, application, approval for various businesses. The main products are pa ...
Capitalization | 79 M USD |
---|---|
Change | 0.00% |
1-year price change | +19.01% |
Metal Bank Limited is a mineral exploration company, which holds a portfolio of copper, cobalt and gold exploration projects. It holds a 75% interest in the advanced Livingstone gold project located 140 kilometers (km) northwest of Meekatharra in Western ...
Capitalization | 7 M USD |
---|---|
Change | +4.17% |
1-year price change | -7.41% |
Arisz Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Compa ...
Capitalization | 13 M USD |
---|---|
Change | -26.91% |
1-year price change | -.--% |
Valuence Merger Corp. I is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It has not select ...
Capitalization | 84 M USD |
---|---|
Change | +0.17% |
1-year price change | +2.50% |
Erasca, Inc. is a clinical-stage precision oncology company. The Company is focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The Company has assembled a wholly owned or controlled RAS/MAP ...
Capitalization | 594 M USD |
---|---|
Change | -0.46% |
1-year price change | +1.88% |
C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on advancing targeted protein degradation science to create a new generation of small-molecule medicines that transform patientsâ lives. By leveraging its proprietary Tar ...
Capitalization | 313 M USD |
---|---|
Change | -0.66% |
1-year price change | -20.00% |
Leap Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing targeted and immuno-oncology therapeutics. Its advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-related protein 1 (D ...
Capitalization | 70 M USD |
---|---|
Change | +9.29% |
1-year price change | -51.75% |
Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targetin ...
Capitalization | 78 M USD |
---|---|
Change | +1.24% |
1-year price change | +10.17% |
AltEnergy Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The C ...
Capitalization | 74 M USD |
---|---|
Change | 0.00% |
1-year price change | +5.14% |
Canna-Global Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It ...
Capitalization | 81 M USD |
---|---|
Change | -1.32% |
1-year price change | -4.14% |
Exact Therapeutics AS is a Norway-based clinical-stage biopharmaceutical company, which develops ultrasound-mediated technology platform for targeted therapeutic enhancement Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-med ...
Capitalization | 20 M USD |
---|---|
Change | 0.00% |
1-year price change | -44.17% |
Social Capital Suvretta Holdings Corp. I is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. ...
Capitalization | 182 M USD |
---|---|
Change | -0.62% |
1-year price change | -90.51% |
International Media Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It ...
Capitalization | 87 M USD |
---|---|
Change | 0.00% |
1-year price change | +1.59% |
Prism Biolab Co Ltd is a Japan-based company mainly engaged in drug discovery business. The Company operates through japan drug discovery business segment. The Company builds a new drug discovery platform and develops new drugs. The Company conducts resea ...
Capitalization | 131 M USD |
---|---|
Change | -4.18% |
1-year price change | 0.00% |
ME Therapeutics Holdings Inc. is a Canada-based biotechnology company. The Company is involved in the discovery and development of novel immuno oncology therapeutics targeting immune suppression in cancer. The Companyâs lead candidate is a novel high af ...
Capitalization | 85 M USD |
---|---|
Change | +22.50% |
1-year price change | +308.33% |
Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH ...
Capitalization | 27 M USD |
---|---|
Change | -0.36% |
1-year price change | -0.01% |
Keyarch Acquisition Corporation is a blank check company. The Company is formed for the purpose of entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more bus ...
Capitalization | 25 M USD |
---|---|
Change | -54.95% |
1-year price change | -62.28% |
Social Capital Suvretta Holdings Corp. III is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses ...
Capitalization | 241 M USD |
---|---|
Change | -3.43% |
1-year price change | -77.13% |
FTAC Emerald Acquisition Corp. is a blank check company. The Company is formed for the purpose of entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more busi ...
Capitalization | 155 M USD |
---|---|
Change | 0.00% |
1-year price change | +2.18% |
Enphys Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It ...
Capitalization | 163 M USD |
---|---|
Change | 0.00% |
1-year price change | +2.91% |
Icosavax, Inc. is a biopharmaceutical company. The Company uses its virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with a focus on life-threatening respiratory diseases. Its VLP platform technology is design ...
Capitalization | 778 M USD |
---|---|
Change | -0.91% |
1-year price change | -2.67% |
Immunome, Inc. is a biotechnology company engaged in developing targeted cancer therapies. The Company's portfolio pursues each target with a modality appropriate to its biology, including immunotherapies, radioligand therapies and Antibody-Drug Conjugate ...
Capitalization | 727 M USD |
---|---|
Change | -0.74% |
1-year price change | +12.43% |
Stanley Lifestyles Ltd is an India-based company operating a super-premium and luxury furniture brand. It retails its furniture products under the Stanley brand. Its product portfolio includes sofas, cabinetry and furniture for living rooms, dining rooms, ...
Capitalization | 333 M USD |
---|---|
Change | -0.19% |
1-year price change | 0.00% |
IGM Biosciences, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing and delivering a new class of medicines to treat patients with cancer and autoimmune and inflammatory diseases. The Companyâs pipeline of clinical and ...
Capitalization | 381 M USD |
---|---|
Change | -2.64% |
1-year price change | -24.43% |
Marblegate Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The ...
Capitalization | 128 M USD |
---|---|
Change | -0.46% |
1-year price change | +3.65% |
Colombier Acquisition Corp. II is a blank check company. The Company is formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has n ...
Capitalization | 218 M USD |
---|---|
Change | -0.05% |
1-year price change | 0.00% |
Birchtree Investments Ltd. is a Canada-based investment company. The Company's business objective is to give its shareholders the opportunity to indirectly participate in investments in the early stages of a target company's development; technologies that ...
Capitalization | 1 M USD |
---|---|
Change | 0.00% |
1-year price change | +150.00% |
Future Medicine Co Ltd is a Korea-based company mainly engaged in the synthetic drug development business. The Company is engaged in the development and sale of anti-inflammatory and anti-fibrotic agents, targeted anticancer drugs, immune anticancer drugs ...
Capitalization | 19 M USD |
---|---|
Change | 0.00% |
1-year price change | -59.68% |
Goldenstone Acquisition Limited is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more bus ...
Capitalization | 77 M USD |
---|---|
Change | -.--% |
1-year price change | +4.37% |
Cantabio Pharmaceuticals Inc. is a preclinical stage biotechnology company. The Company is focused on commercializing therapies and the intellectual property generated from its research and development activities for Parkinsonâs disease (PD), Alzheimerâ ...
Capitalization | 24 348 USD |
---|---|
Change | -95.96% |
1-year price change | -.--% |
Pyxis Oncology, Inc. is a clinical-stage company focused on developing therapeutics to target difficult-to-treat cancers. The Company is building therapeutics that hold the potential for mono and combination therapies. Its clinical program portfolio inclu ...
Capitalization | 170 M USD |
---|---|
Change | +0.69% |
1-year price change | +61.11% |